Evolução das mutações de resistência aos inibidores de protease em pacientes infectados pelo HIV-1 subtipo F

Elisabeth Nicand, Melanie Caron, Christophe Rogier, Jérôme Maslin, Jean-Louis Koeck, Marc Grandadam, Short communication. Antiretroviral drug resistance among drug-naive HIV-1-infected individuals in Djibouti (Horn of Africa). Antiviral Therapy. ,vol. 10, pp. 855- 859 ,(2005)

Markowitz M, Gulnik Sv, Erickson Jw, Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies. AIDS. ,vol. 13, ,(1999)

J B Jowett, V Planelles, B Poon, N P Shah, M L Chen, I S Chen, The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle Journal of Virology. ,vol. 69, pp. 6304- 6313 ,(1995) , 10.1128/JVI.69.10.6304-6313.1995

Jonathan M. Schapiro, Robert W. Shafer, HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. Aids Reviews. ,vol. 10, pp. 67- 84 ,(2008)

F Clavel, M D Hoggan, R L Willey, K Strebel, M A Martin, R Repaske, Genetic recombination of human immunodeficiency virus. Journal of Virology. ,vol. 63, pp. 1455- 1459 ,(1989) , 10.1128/JVI.63.3.1455-1459.1989

F Boulerice, X G Li, A Lvovich, M A Wainberg, Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells. Journal of Virology. ,vol. 65, pp. 5589- 5592 ,(1991) , 10.1128/JVI.65.10.5589-5592.1991

T. Pumarola, M. Opravil, N. Hellmann, L. Bacheler, M. Salminen, N. Clumeck, A. Hatzakis, J. Schapiro, A. Horban, A. M. Vandamme, S. Staszewski, J. Albert, L. Palmisano, R. Camacho, S. Vella, D. Kempf, V. Soriano, A. Phillips, L. Perrin, W. W. Hall, B. Schmidt, R. Schuurman, G. Gatti, M. Miller, J. C. Schmit, D. Banhegyi, J. Gerstoft, A. Sönnerborg, J. D. Lundgren, V. Miller, C. F. Perno, C. Nielsen, J. L. Faudon, L. Ruiz, B. Asjo, C. Boucher, A. De Luca, D. Pillay, F. Brun-Vézinet, P. Clevenbergh, H. W. Doerr, M. Youle, T. W. Myers, E. Shulse, N. Dedes, M. Ait-Khaled, R. Ziermann, Updated European recommendations for the clinical use of HIV drug resistance testing Antiviral Therapy. ,vol. 9, pp. 829- 848 ,(2004)

Pavel Pugach, Thomas J. Ketas, Elizabeth Michael, John P. Moore, Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors. Virology. ,vol. 377, pp. 401- 407 ,(2008) , 10.1016/J.VIROL.2008.04.032

Marcelo A Soares, Rodrigo M Brindeiro, Amilcar Tanuri, Primary HIV-1 drug resistance in Brazil. AIDS. ,vol. 18, ,(2004) , 10.1097/00002030-200406003-00003

Joseph C Gathe, Prudence Ive, Robin Wood, Dirk Schürmann, Nicholaos C Bellos, Edwin DeJesus, Andrzej Gladysz, Cindy Garris, Jane Yeo, SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients. AIDS. ,vol. 18, pp. 1529- 1537 ,(2004) , 10.1097/01.AIDS.0000131332.30548.92